Print ISSN:-2394-2789

Online ISSN:-2394-2797

CODEN : IJPCN9

Article History

Received : 25-11-2022

Accepted : 13-12-2022



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 272

PDF Downloaded: 147


Recent advances in the biological activity of quinazoline


Full Text PDF Share on Facebook Share on Twitter


Review Article

Author Details : Sudarshan Nagrale*, Amit Pondkule, Vishal Babar

Volume : 9, Issue : 4, Year : 2022

Article Page : 169-173

https://doi.org/10.18231/j.ijpca.2022.031



Suggest article by email

Get Permission

Abstract

The aim of this review is to produce an outline of numerous pharmacologic activities of quinazoline moiety. Quinazoline has become a famous topic up of two fused six-membered simple aromatic rings, a benzene ring and a pyrimidine ring because of its manifold uses. various quinazoline derivatives have been found to gives a broad spectrum of biological activities, which stimulated the research activity in this field. Quinazolines and its derivatives represent one in all the foremost active categories of compounds, that possess wide selection of biological activities like anti-bacterial, analgesic, anti-microbial, anti-inflammatory drug, anticancer, and anti-hypertensive, antifungal, anti-HIV, inhibitor, analgesic, medicament, antiprotozoal, antitumor, anti-tubercular activities. This review is an effort to magnify the immense potentiality of this ring system. This study may accelerate the designing process to come up with a lot of range of therapeutically viable clinical candidates.


Keywords: Quinazoline, Anti­cancer activity, Anti­microbial activity, Anti­HIV activity



How to cite : Nagrale S, Pondkule A, Babar V, Recent advances in the biological activity of quinazoline. Int J Pharm Chem Anal 2022;9(4):169-173


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.